The production capacity from the new facility in the US is on...

The production capacity from the new facility in the US is on top of the existing capacity in Australia .
The action taken points to a real forecast demand increase and will rectify current supply capacity strain from Lucas Heights alluded to in the recent quater report .

The recent US Mayo Clinic report demonstrates actual expanded procedure base and cosequently will lead to sales increases . There is no disputng the success of Sirtex treatment in saving terminally ill patients . The word is obviously getting around .

Some may have been disappointed by the reduction of cash in hand but, as Pheenom points out, if the new US capacity is utilized the recent expenditure will expand cash on hand rapidly .

41% growth for the half year to date, taking into account sales supply strain is brilliant and quite unrecognized by the ASX .